Charles Schwab’s Icosavax, Inc. Common Stock ICVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-82,642
| Closed | -$1.3M | – | 3551 |
|
|
2023
Q4 | $1.3M | Buy |
82,642
+10,783
| +15% | +$170K | ﹤0.01% | 2755 |
|
|
2023
Q3 | $557K | Hold |
71,859
| – | – | ﹤0.01% | 3007 |
|
|
2023
Q2 | $714K | Buy |
71,859
+13,126
| +22% | +$130K | ﹤0.01% | 2891 |
|
|
2023
Q1 | $341K | Hold |
58,733
| – | – | ﹤0.01% | 3056 |
|
|
2022
Q4 | $466K | Buy |
58,733
+9,894
| +20% | +$78.6K | ﹤0.01% | 3022 |
|
|
2022
Q3 | $155K | Sell |
48,839
-4,633
| -9% | -$14.7K | ﹤0.01% | 3190 |
|
|
2022
Q2 | $307K | Sell |
53,472
-5,080
| -9% | -$29.2K | ﹤0.01% | 3185 |
|
|
2022
Q1 | $413K | Buy |
58,552
+24,820
| +74% | +$175K | ﹤0.01% | 3135 |
|
|
2021
Q4 | $772K | Buy |
33,732
+975
| +3% | +$22.3K | ﹤0.01% | 3010 |
|
|
2021
Q3 | $970K | Buy |
+32,757
| New | +$970K | ﹤0.01% | 2885 |
|